ATE342258T1 - N-aryl-2-oxazolidinon-5-carbonsäureamide und deren derivate und deren verwendung als antibakterielle mittel - Google Patents
N-aryl-2-oxazolidinon-5-carbonsäureamide und deren derivate und deren verwendung als antibakterielle mittelInfo
- Publication number
- ATE342258T1 ATE342258T1 AT03743112T AT03743112T ATE342258T1 AT E342258 T1 ATE342258 T1 AT E342258T1 AT 03743112 T AT03743112 T AT 03743112T AT 03743112 T AT03743112 T AT 03743112T AT E342258 T1 ATE342258 T1 AT E342258T1
- Authority
- AT
- Austria
- Prior art keywords
- oxazolidinone
- aryl
- derivatives
- carbonic acid
- acid amides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/12—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35949502P | 2002-02-25 | 2002-02-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE342258T1 true ATE342258T1 (de) | 2006-11-15 |
Family
ID=27766097
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03743112T ATE342258T1 (de) | 2002-02-25 | 2003-02-24 | N-aryl-2-oxazolidinon-5-carbonsäureamide und deren derivate und deren verwendung als antibakterielle mittel |
Country Status (36)
Country | Link |
---|---|
US (1) | US6919329B2 (de) |
EP (1) | EP1478629B1 (de) |
JP (1) | JP2005524660A (de) |
KR (1) | KR100613532B1 (de) |
CN (1) | CN1639135A (de) |
AP (1) | AP1902A (de) |
AR (1) | AR038536A1 (de) |
AT (1) | ATE342258T1 (de) |
AU (1) | AU2003210807A1 (de) |
BR (1) | BR0307924A (de) |
CA (1) | CA2476038A1 (de) |
CO (1) | CO5611128A2 (de) |
CY (1) | CY1105797T1 (de) |
DE (1) | DE60308998T2 (de) |
DK (1) | DK1478629T3 (de) |
EA (1) | EA007490B1 (de) |
EC (1) | ECSP045245A (de) |
ES (1) | ES2271615T3 (de) |
GE (1) | GEP20074198B (de) |
HR (1) | HRP20040717A2 (de) |
IS (1) | IS7376A (de) |
MA (1) | MA27180A1 (de) |
MX (1) | MXPA04008205A (de) |
MY (1) | MY135233A (de) |
NO (1) | NO20044062L (de) |
NZ (1) | NZ534521A (de) |
OA (1) | OA12779A (de) |
PL (1) | PL372461A1 (de) |
PT (1) | PT1478629E (de) |
SI (1) | SI1478629T1 (de) |
TN (1) | TNSN04163A1 (de) |
TW (1) | TW200305568A (de) |
UA (1) | UA80112C2 (de) |
WO (1) | WO2003072553A1 (de) |
YU (1) | YU72804A (de) |
ZA (1) | ZA200406362B (de) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7141588B2 (en) * | 2002-02-25 | 2006-11-28 | Pfizer, Inc. | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives |
EP1554273A1 (de) * | 2002-10-10 | 2005-07-20 | Pharmacia & Upjohn Company LLC | Antimikrobielle 1-aryldihydropyridonverbindungen |
EP1615916A1 (de) * | 2003-04-09 | 2006-01-18 | Pharmacia & Upjohn Company LLC | Antimikrobielle [3.1.0]bicyclohexylphenyloxazolidinonderivate und analoge |
US8324398B2 (en) | 2003-06-03 | 2012-12-04 | Rib-X Pharmaceuticals, Inc. | Process for the synthesis of biaryl oxazolidinones |
US6969726B2 (en) | 2003-06-03 | 2005-11-29 | Rib X Pharmaceuticals Inc | Biaryl heterocyclic compounds and methods of making and using the same |
AU2004256084B2 (en) * | 2003-07-02 | 2007-10-18 | Kyorin Pharmaceutical Co., Ltd. | Oxazolidinone antibiotics and derivatives thereof |
DE602004027811D1 (de) | 2003-07-02 | 2010-08-05 | Kyorin Seiyaku Kk | Cyclopropylgruppensubstituierte oxazolidinonantibiotika und derivate davon |
TW200526626A (en) | 2003-09-13 | 2005-08-16 | Astrazeneca Ab | Chemical compounds |
US7304050B2 (en) * | 2003-09-16 | 2007-12-04 | Pfizer Inc. | Antibacterial agents |
EP1713785A1 (de) | 2003-12-17 | 2006-10-25 | Rib-X Pharmaceuticals, Inc. | Halogenierte heterocyclische biarylverbindungen und verfahren zu deren herstellung und verwendung |
KR100854211B1 (ko) * | 2003-12-18 | 2008-08-26 | 동아제약주식회사 | 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물 |
WO2005082900A2 (en) * | 2004-01-28 | 2005-09-09 | Pharmacia & Upjohn Company Llc | Oxazolidinone amidoximes as antibacterial agents |
CA2576041A1 (en) * | 2004-08-06 | 2006-02-16 | Pharmacia & Upjohn Company Llc | Oxazolidinones containing oxindoles as antibacterial agents |
JP2008521792A (ja) * | 2004-11-29 | 2008-06-26 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | 抗菌薬としてのジアゼピンオキサゾリジノン |
EE05394B1 (et) * | 2004-12-24 | 2011-04-15 | Janssen Pharmaceutica N.V. | Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis |
NZ561613A (en) | 2005-02-18 | 2010-12-24 | Astrazeneca Ab | Antibacterial piperidine derivatives |
AU2006231919A1 (en) | 2005-04-06 | 2006-10-12 | Pharmacia & Upjohn Company Llc | 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents |
EP1874782A1 (de) | 2005-04-15 | 2008-01-09 | Ranbaxy Laboratories Limited | Oxazolidinon-derivate als antimikrobielle mittel |
JP5534497B2 (ja) | 2005-06-08 | 2014-07-02 | メリンタ セラピューティクス,インコーポレイテッド | トリアゾール類の合成方法 |
JP2008544979A (ja) | 2005-06-29 | 2008-12-11 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | 抗菌剤としてのホモモルホリンオキサゾリジノン |
JP2009500389A (ja) * | 2005-07-06 | 2009-01-08 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | 抗菌剤としてのアゼチジンおよびシクロブタンを含むオキサゾリジノンカルボキサミド |
WO2007004032A1 (en) * | 2005-07-06 | 2007-01-11 | Pharmacia & Upjohn Company Llc | Oxazolidiones containing cyclobutane as antibacterial agents |
US20080312211A1 (en) * | 2005-12-23 | 2008-12-18 | Astrazeneca Ab | Antibacterial Pyrrolopyridines, Pyrrolopyrimidines and Pyrroloazepines-154 |
WO2007088478A1 (en) * | 2006-02-01 | 2007-08-09 | Pfizer Products Inc. | Indazole oxazolidinones as antibacterial agents |
CN101460495B (zh) * | 2006-03-31 | 2013-08-14 | 财团法人乙卯研究所 | 具有杂环的化合物 |
JP5187901B2 (ja) * | 2006-08-30 | 2013-04-24 | 塩野義製薬株式会社 | ヒドラジンアミド誘導体 |
US8088777B2 (en) | 2006-08-30 | 2012-01-03 | Shionogi & Co., Ltd. | Urea derivative |
EP2185549B1 (de) * | 2007-08-06 | 2018-10-03 | Micurx Pharmaceuticals, Inc. | Antimikrobielle ortho-fluorphenyloxazolidinone zur behandlung bakterieller infektionen |
US8530646B2 (en) | 2007-10-02 | 2013-09-10 | Research Foundation Itsuu Laboratory | Oxazolidinone derivative having 7-membered hetero ring |
US9540322B2 (en) | 2008-08-18 | 2017-01-10 | Yale University | MIF modulators |
US9643922B2 (en) | 2008-08-18 | 2017-05-09 | Yale University | MIF modulators |
US20120040974A1 (en) * | 2008-08-18 | 2012-02-16 | Yale University | Mif modulators |
JP5662940B2 (ja) * | 2008-11-20 | 2015-02-04 | パナセア バイオテック リミテッド | 新規な抗微生物薬 |
CN102439006A (zh) | 2009-02-03 | 2012-05-02 | 特留斯治疗学公司 | (r)-3-(4-(2-(2-甲基四唑-5-基)吡啶-5-基)-3-氟苯基)-5-羟甲基噁唑烷-2-酮二氢磷酸酯的晶型 |
KR20120106697A (ko) | 2009-06-26 | 2012-09-26 | 파나세아 바이오테크 리미티드 | 신규 아자비시클로헥산 |
WO2012007500A2 (de) | 2010-07-15 | 2012-01-19 | Bayer Cropscience Ag | Neue heterocyclische verbindungen als schädlingsbekämpfungsmittel |
UA112897C2 (uk) | 2012-05-09 | 2016-11-10 | Байєр Фарма Акцієнгезелльшафт | Біциклічно заміщені урацили та їх застосування для лікування і/або профілактики захворювань |
CN105612166B (zh) | 2014-02-21 | 2019-02-19 | 上海盟科药业有限公司 | 治疗用水溶性(o-羰基)氨基磷酸酯前药 |
JP7205529B2 (ja) * | 2018-02-26 | 2023-01-17 | 住友化学株式会社 | オキサゾリジノン化合物の製造方法 |
Family Cites Families (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4705799A (en) | 1983-06-07 | 1987-11-10 | E. I. Du Pont De Nemours And Company | Aminomethyl oxooxazolidinyl benzenes useful as antibacterial agents |
US5043443A (en) | 1988-07-29 | 1991-08-27 | Du Pont Merck Pharmaceutical Company | Aminomethyloxooxazolidinyl arylbenzene derivatives |
US5164510A (en) | 1988-09-15 | 1992-11-17 | The Upjohn Company | 5'Indolinyl-5β-amidomethyloxazolidin-2-ones |
US5182403A (en) | 1988-09-15 | 1993-01-26 | The Upjohn Company | Substituted 3(5'indazolyl) oxazolidin-2-ones |
US5225565A (en) | 1988-09-15 | 1993-07-06 | The Upjohn Company | Antibacterial 3-(fused-ring substituted)phenyl-5β-amidomethyloxazolidin-2-ones |
EP0417044A3 (en) | 1989-09-07 | 1991-06-12 | Ciba-Geigy Ag | Oxazolidinones and thiones as plantgrowth regulators |
US5231188A (en) | 1989-11-17 | 1993-07-27 | The Upjohn Company | Tricyclic [6.5.51]-fused oxazolidinone antibacterial agents |
AU667198B2 (en) | 1991-11-01 | 1996-03-14 | Pharmacia & Upjohn Company | Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents |
SK283420B6 (sk) | 1992-05-08 | 2003-07-01 | Pharmacia & Upjohn Company | Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny |
EP0648119A1 (de) | 1992-07-08 | 1995-04-19 | The Upjohn Company | Gegen mycobacterium tuberculosis verwendbare 5'-indolinyloxazolidinone |
KR100276382B1 (ko) | 1992-12-08 | 2000-12-15 | 로렌스 티. 마이젠헬더 | 트로폰-치환된 페닐옥사졸리디논 항균제 |
US5688792A (en) | 1994-08-16 | 1997-11-18 | Pharmacia & Upjohn Company | Substituted oxazine and thiazine oxazolidinone antimicrobials |
MY115155A (en) | 1993-09-09 | 2003-04-30 | Upjohn Co | Substituted oxazine and thiazine oxazolidinone antimicrobials. |
DE69419523T2 (de) | 1993-11-22 | 1999-11-25 | Upjohn Co | Substituierte hydroxyacetyl piperazine phenyl oxazolidinonsäureester |
JPH0873455A (ja) | 1994-03-15 | 1996-03-19 | Upjohn Co:The | オキサゾリジノン誘導体及びこれを有効成分とする医薬組成物 |
DE4425609A1 (de) | 1994-07-20 | 1996-01-25 | Bayer Ag | Benzofuranyl- und Benzothienyloxazolidinone |
DE4425613A1 (de) | 1994-07-20 | 1996-01-25 | Bayer Ag | 5-gliedrige Heteroaryl-oxazolidinone |
DE4425612A1 (de) | 1994-07-20 | 1996-04-04 | Bayer Ag | 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone |
DE19514313A1 (de) | 1994-08-03 | 1996-02-08 | Bayer Ag | Benzoxazolyl- und Benzothiazolyloxazolidinone |
DE4429461A1 (de) | 1994-08-19 | 1996-02-22 | Merck Patent Gmbh | Adhäsionsrezeptor-Antagonisten |
CA2200433C (en) | 1994-10-26 | 2006-02-07 | Douglas K. Hutchinson | Phenyloxazolidinone antimicrobials |
AU702733B2 (en) | 1994-11-15 | 1999-03-04 | Pharmacia & Upjohn Company | Bicyclic oxazine and thiazine oxazolidinone antibacterials |
RU2154645C2 (ru) | 1995-02-03 | 2000-08-20 | Фармация Энд Апджон Компани | Фенилоксазолидиноны, замещенные в кольце гетероароматическими кольцами, в качестве антимикробных агентов |
HRP960159A2 (en) | 1995-04-21 | 1997-08-31 | Bayer Ag | Benzocyclopentane oxazolidinones containing heteroatoms |
ES2162047T3 (es) | 1995-05-11 | 2001-12-16 | Upjohn Co | Oxazolidinonas con resto diazinilo y carbazinilo espirociclico y biciclico. |
US5968962A (en) | 1995-09-01 | 1999-10-19 | Pharmacia & Upjohn Company | Phenyloxazolidinones having a C-C bond to 4-8 membered heterocyclic rings |
DE19601264A1 (de) | 1996-01-16 | 1997-07-17 | Bayer Ag | Pyrido-annellierte Thienyl- und Furanyl-Oxazolidinone |
DE19601265A1 (de) | 1996-01-16 | 1997-07-17 | Bayer Ag | 2-Oxo- und 2-Thio-1,2-dihydrochinolinyl-oxazolidinone |
DE19601627A1 (de) | 1996-01-18 | 1997-07-24 | Bayer Ag | Heteroatomhaltige Cyclopentanopyridyl-Oxazolidinone |
GB9601666D0 (en) | 1996-01-27 | 1996-03-27 | Zeneca Ltd | Chemical compounds |
DE19604223A1 (de) | 1996-02-06 | 1997-08-07 | Bayer Ag | Neue substituierte Oxazolidinone |
GB9702213D0 (en) | 1996-02-24 | 1997-03-26 | Zeneca Ltd | Chemical compounds |
GB9609919D0 (en) | 1996-05-11 | 1996-07-17 | Zeneca Ltd | Chemical compounds |
PT920421E (pt) | 1996-08-21 | 2003-03-31 | Upjohn Co | Derivados de isoxazolina uteis como agentes antimicrobianos |
WO1998054161A1 (en) | 1997-05-30 | 1998-12-03 | Pharmacia & Upjohn Company | Oxazolidinone antibacterial agents having a thiocarbonyl functionality |
DE19730847A1 (de) | 1997-07-18 | 1999-01-28 | Bayer Ag | Tricyclisch substituierte Oxazolidinone |
GB9717804D0 (en) | 1997-08-22 | 1997-10-29 | Zeneca Ltd | Chemical compounds |
US6083967A (en) | 1997-12-05 | 2000-07-04 | Pharmacia & Upjohn Company | S-oxide and S,S-dioxide tetrahydrothiopyran phenyloxazolidinones |
DE19802239A1 (de) | 1998-01-22 | 1999-07-29 | Bayer Ag | Neue mit Bicyclen substituierte Oxazolidinone |
DE19802235A1 (de) | 1998-01-22 | 1999-07-29 | Bayer Ag | Mit tricyclischen Indolen substituierte Oxazolidinone |
CA2318969A1 (en) | 1998-01-23 | 1999-07-29 | Mikhail F. Gordeev | Oxazolidinone combinatorial libraries, compositions and methods of preparation |
DE19805117A1 (de) | 1998-02-09 | 1999-08-12 | Bayer Ag | Neue Oxazolidinone mit azolhaltigen Tricyclen |
HUP0103082A3 (en) | 1998-06-05 | 2002-12-28 | Astrazeneca Ab | Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them |
GB9821938D0 (en) | 1998-10-09 | 1998-12-02 | Zeneca Ltd | Chemical compounds |
DE60019630T2 (de) | 1999-02-01 | 2006-03-16 | Pharmacia & Upjohn Co. Llc, Kalamazoo | 2-Fluoro-(oxido-Thiopyran-4-yl)Benzol Derivate |
CN1142162C (zh) | 1999-05-27 | 2004-03-17 | 法玛西雅厄普约翰美国公司 | 作为抗菌剂的新的双环噁唑烷酮 |
GB9928499D0 (en) | 1999-12-03 | 2000-02-02 | Zeneca Ltd | Chemical processes and intermediates |
CA2389482A1 (en) | 1999-12-21 | 2001-06-28 | Jackson B. Hester, Jr. | Oxazolidinones having a sulfoximine functionality and their use as antimicrobial agents |
GB0009803D0 (en) | 2000-04-25 | 2000-06-07 | Astrazeneca Ab | Chemical compounds |
GB0100110D0 (en) | 2001-01-04 | 2001-02-14 | Univ Leeds | Modulation of calcium channel activity |
GB0113297D0 (en) | 2001-06-01 | 2001-07-25 | Astrazeneca Ab | Chemical Process |
JP2005520782A (ja) * | 2001-07-12 | 2005-07-14 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | 向上した水溶解度を有するアミド含有化合物およびアミド含有化合物の水溶解度を向上させる方法 |
-
2003
- 2003-02-20 AR ARP030100552A patent/AR038536A1/es unknown
- 2003-02-21 MY MYPI20030608A patent/MY135233A/en unknown
- 2003-02-24 EA EA200400893A patent/EA007490B1/ru not_active IP Right Cessation
- 2003-02-24 AU AU2003210807A patent/AU2003210807A1/en not_active Abandoned
- 2003-02-24 AT AT03743112T patent/ATE342258T1/de not_active IP Right Cessation
- 2003-02-24 CA CA002476038A patent/CA2476038A1/en not_active Abandoned
- 2003-02-24 BR BR0307924-4A patent/BR0307924A/pt not_active IP Right Cessation
- 2003-02-24 NZ NZ534521A patent/NZ534521A/en unknown
- 2003-02-24 ES ES03743112T patent/ES2271615T3/es not_active Expired - Lifetime
- 2003-02-24 DE DE60308998T patent/DE60308998T2/de not_active Expired - Lifetime
- 2003-02-24 GE GEAP8378A patent/GEP20074198B/en unknown
- 2003-02-24 PL PL03372461A patent/PL372461A1/xx unknown
- 2003-02-24 EP EP03743112A patent/EP1478629B1/de not_active Expired - Lifetime
- 2003-02-24 US US10/373,286 patent/US6919329B2/en not_active Expired - Fee Related
- 2003-02-24 AP APAP/P/2004/003110A patent/AP1902A/en active
- 2003-02-24 MX MXPA04008205A patent/MXPA04008205A/es active IP Right Grant
- 2003-02-24 KR KR1020047013297A patent/KR100613532B1/ko not_active IP Right Cessation
- 2003-02-24 CN CNA038044986A patent/CN1639135A/zh active Pending
- 2003-02-24 UA UA20040807036A patent/UA80112C2/uk unknown
- 2003-02-24 SI SI200330518T patent/SI1478629T1/sl unknown
- 2003-02-24 JP JP2003571259A patent/JP2005524660A/ja active Pending
- 2003-02-24 OA OA1200400221A patent/OA12779A/en unknown
- 2003-02-24 DK DK03743112T patent/DK1478629T3/da active
- 2003-02-24 WO PCT/US2003/003125 patent/WO2003072553A1/en active IP Right Grant
- 2003-02-24 PT PT03743112T patent/PT1478629E/pt unknown
- 2003-02-24 YU YU72804A patent/YU72804A/sh unknown
- 2003-02-25 TW TW092103898A patent/TW200305568A/zh unknown
-
2004
- 2004-07-29 IS IS7376A patent/IS7376A/is unknown
- 2004-08-06 HR HR20040717A patent/HRP20040717A2/hr not_active Application Discontinuation
- 2004-08-11 ZA ZA200406362A patent/ZA200406362B/xx unknown
- 2004-08-13 CO CO04079406A patent/CO5611128A2/es not_active Application Discontinuation
- 2004-08-24 MA MA27837A patent/MA27180A1/fr unknown
- 2004-08-24 TN TNP2004000163A patent/TNSN04163A1/fr unknown
- 2004-08-25 EC EC2004005245A patent/ECSP045245A/es unknown
- 2004-09-24 NO NO20044062A patent/NO20044062L/no not_active Application Discontinuation
-
2006
- 2006-11-17 CY CY20061101682T patent/CY1105797T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE342258T1 (de) | N-aryl-2-oxazolidinon-5-carbonsäureamide und deren derivate und deren verwendung als antibakterielle mittel | |
DE602005013491D1 (de) | Benzamidderivate und deren verwendung als glucokinaseaktivierende mittel | |
ATE490240T1 (de) | Mutilinderivate und deren verwendung als antimikrobielle agenzien | |
ATE395339T1 (de) | Biphenylderivate und deren verwendung als fungizide | |
DE60332023D1 (de) | Chinolinderivate und deren verwendung als mycobakterielle inhibitoren | |
DE60329318D1 (de) | 4-oxochinolinverbindungen und deren verwendung als hiv-integrase-inhibitoren | |
ATE462691T1 (de) | Trifluormethylpyrrolcarbonsäureamide und trifluormethylpyrrolthiocarbonsäureamide als fungizide | |
DE60113719D1 (de) | Chinuclidincarbamat derivate und deren verwendung als m3 antagonisten | |
DE60309856D1 (de) | Substituierte phenylacetamide und deren verwendung als glucokinaseaktivatoren | |
DE602004021904D1 (de) | Gyraseinhibitoren und deren verwendungen | |
ATE524178T1 (de) | Acylierte, heteroaryl-kondensierte cycloalkenylamine und deren verwendung als arzneimittel | |
ATE419849T1 (de) | Diaminotriazole derivate und deren verwendung als protein kinase inhibitoren | |
ATE420084T1 (de) | Neue imidazolderivate und deren verwendung als pharmazeutische mittel | |
DE60202876D1 (de) | 6 aryl 4 aminopicolinate und deren verwendung als herbizide | |
ATE367381T1 (de) | Neue spirotricyclische derivate und deren verwendung als phosphodiesterase-7-inhibitoren | |
DE60235492D1 (de) | Beta-amino-alpha-cyanoacrylate und deren verwendung als herbizide | |
ATE482957T1 (de) | Arylessigsäure- und esterderivate und deren verwendung als entzündungshemmende mittel | |
DE60325493D1 (de) | Substituierte 1,4-dipiperidin-4-yl-piperazinderivate und deren verwendung als neurokininantagonisten | |
ATE500242T1 (de) | Substituierte 1-piperidin-4-yl-pyrrolidin-3-yl- piperazinderivate und deren verwendung als neurokinin antagonisten | |
DE50111690D1 (de) | 2-acyl-indolderivate und deren verwendung als antitumormittel | |
DE60216345D1 (de) | Gummimischung und deren Verwendung | |
ATE323694T1 (de) | Cyanoanthranylamid-derivate und deren verwendung als arzneimittel | |
DE602004008668D1 (de) | Benzoxazinderivate und deren verwendungen | |
ATE388935T1 (de) | N-alkynyl-2-(substituierte phenoxy)-alkylamide und deren verwendung als fungizide | |
DE60311277D1 (de) | Benzotriazabicyclische derivate und deren verwendung als beta-lactamaseinhibitoren und antibakterielle mittel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1478629 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |